Skip to content
Trial Eligibility
Menu

COPD Clinical Trials near Philadelphia, PA

25 studies for COPD are recruiting at 38 sites within 50 miles of Philadelphia, Pennsylvania, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all COPD trials in the US or all trials near Philadelphia.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

COPD studies enrolling near Philadelphia

Showing 25 studies, nearest first.
  1. myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

    NCT05204888

    • Interventional
    • Ages 30 years and older
    • Sex: All

    Nearest sites: Jeanes Hospital (Philadelphia, PA); Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  2. Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

    NCT06122077

    • Observational
    • Ages 50 years and older
    • Sex: All

    Nearest sites: Temple University (Philadelphia, PA); Inspira Medical Center (Mullica Hill, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

    NCT06283966

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: Research Site (Philadelphia, PA); Research Site (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

    NCT06883305

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: Research Site (Philadelphia, PA); Research Site (Sewell, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

    NCT06961214

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: GSK Investigational Site (Philadelphia, PA); GSK Investigational Site (Moorestown, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  6. An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

    NCT06035120

    • Interventional
    • Ages 40 to 80 years
    • Sex: All

    Nearest sites: Penn Medicine (Philadelphia, PA); Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    NCT07082738

    • Phase 2
    • Ages 40 years and older
    • Sex: All

    Nearest sites: Research Site (Philadelphia, PA); Research Site (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. COPD Exacerbation Follow Up

    NCT07118306

    • Observational
    • Ages 40 years and older
    • Sex: All

    Nearest sites: Thomas Jefferson University (Philadelphia, PA); Cooper University Health Care (Cherry Hill, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. STRIVE Post-Market Registry Study

    NCT04302272

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. SPIROMICS Study of Early COPD Progression (SOURCE)

    NCT05033990

    • Observational
    • Ages 30 to 55 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Feasibility of Semaglutide in Advanced Lung Disease

    NCT05746039

    • Phase 1/2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: University of Pennsylvania Perelman School of Medicine (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Supporting Evidence-based Responses to Emotional Needs in Emphysema

    NCT06600126

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Pennsylvania (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

    NCT06891755

    • Interventional
    • Ages 40 to 84 years
    • Sex: All

    Nearest site: Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Temple Health Chest Initiative (THCI 2.0)

    NCT06933758

    • Observational
    • Ages 50 to 80 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Temple University Of the Commonwealth System of Higher Education (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

    NCT06974981

    • Observational
    • Ages 50 to 80 years
    • Sex: All

    Nearest site: Thomas Jefferson University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

    NCT07051707

    • Interventional
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: Temple University - Temple Lung Center (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

    NCT07059091

    • Phase 2
    • Ages 40 years and older
    • Sex: All

    Nearest site: Temple University (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

    NCT07222410

    • Interventional
    • Ages 22 years and older
    • Sex: All

    Nearest site: Temple University Hospital (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

    NCT07684820

    • Phase 2
    • Ages 40 to 85 years
    • Sex: All

    Nearest site: DM Clinical Research - Philadelphia (Philadelphia, PA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

    NCT07177339

    • Phase 3
    • Ages 40 to 75 years
    • Sex: All

    Nearest site: GSK Investigational Site (West Chester, PA)

    Distance to nearest recruiting site
    ~24 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

    NCT06878261

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: Research Site (Wilmington, DE)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

    NCT06959095

    • Phase 3
    • Ages 40 to 80 years
    • Sex: All

    Nearest site: GSK Investigational Site (Wilmington, DE)

    Distance to nearest recruiting site
    ~25 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Multi-Center Clean Air Randomized Controlled Trial in COPD

    NCT06376994

    • Phase 3
    • Ages 40 years and older
    • Sex: All

    Nearest site: Reading Hospital (West Reading, PA)

    Distance to nearest recruiting site
    ~49 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a COPD clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.